FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 295:476-480 August 26, 1976 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To define the histology of the columnarlined esophagus, we obtained esophageal biopsies from various levels with manometric control from 11 patients. There were three types of columnar epithelia above the lower esophageal sphincter: atrophic gastric-fundic-type epithelium with parietal and chief cells; junctional-type epithelium with cardiac mucous glands; and distinctive specialized columnar epithelium with a villiform surface, mucous glands and intestinal-type goblet cells. When present, specialized columnar epithelium was always the most proximal, and gastric fundic epithelium the most distal epithelium. Junctional epithelium was interposed between gastric fundic and specialized columnar or squamous epithelium. Four patients had unequivocal esophagitis in squamous epithelium, but its presence and severity did not correlate with inflammation in or length or type of distal columnar epithelium. Histoligic study of the columnar-lined esophagus demonstrated a spectrum of epithelial patterns. This heterogeneity helps to explain prior discrepant reports.

This article has been cited by other articles:

• Ford, A. C., Forman, D., Reynolds, P. D., Cooper, B. T., Moayyedi, P. (2005). Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's Esophagus. Am J Epidemiol 162: 454-460 [Abstract] [Full Text]  
• Oyama, K., Fujimura, T., Ninomiya, I., Miyashita, T., Kinami, S., Fushida, S., Ohta, T., Koichi, M. (2005). A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats. Carcinogenesis 26: 565-570 [Abstract] [Full Text]  
• Flejou, J-F (2005). Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 54: i6-i12 [Abstract] [Full Text]  
• Mattioli, S., Lugaresi, M. L., Di Simone, M. P., D'Ovidio, F., Pilotti, V., Bassi, F., Brusori, S., Gavelli, G. (2004). The surgical treatment of the intrathoracic migration of the gastro-oesophageal junction and of short oesophagus in gastro-oesophageal reflux disease. Eur. J. Cardiothorac. Surg. 25: 1079-1088 [Abstract] [Full Text]  
• Fitzgerald, R C, Abdalla, S, Onwuegbusi, B A, Sirieix, P, Saeed, I T, Burnham, W R, Farthing, M J G (2002). Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut 51: 316-322 [Abstract] [Full Text]  
• Rugge, M, Russo, V, Busatto, G, Genta, R M, Di Mario, F, Farinati, F, Graham, D Y (2001). The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J. Clin. Pathol. 54: 456-460 [Abstract] [Full Text]  
• Arul, G S, Moorghen, M, Myerscough, N, Alderson, D A, Spicer, R D, Corfield, A P (2000). Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 47: 753-761 [Abstract] [Full Text]  
• Ibrahim, N. B N (2000). ACP Best Practice No. 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting. J. Clin. Pathol. 53: 89-94 [Full Text]  
• Peters, F T M, Ganesh, S, Kuipers, E J, Sluiter, W J, Klinkenberg-Knol, E C, Lamers, C B H W, Kleibeuker, J H (1999). Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut 45: 489-494 [Abstract] [Full Text]  
• Morales, T. G., Sampliner, R. E. (1999). Barrett's Esophagus: Update on Screening, Surveillance, and Treatment. Arch Intern Med 159: 1411-1416 [Abstract] [Full Text]  
• Mattioli, S., D'Ovidio, F., Di Simone, M. P., Bassi, F., Brusori, S., Pilotti, V., Felice, V., Ferruzzi, L., Guernelli, N. (1998). Clinical and surgical relevance of the progressive phases of intrathoracic migration of the gastroesophageal junction in gastroesophageal reflux disease. J. Thorac. Cardiovasc. Surg. 116: 267-275 [Abstract] [Full Text]  
• van Sandick, J W, van Lanschot, J J B, Kuiken, B W, Tytgat, G N J, Offerhaus, G J A, Obertop, H (1998). Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43: 216-222 [Abstract] [Full Text]  
• Hackelsberger, A, Gunther, T, Schultze, V, Manes, G, Dominguez-Munoz, J-E, Roessner, A, Malfertheiner, P (1998). Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?. Gut 43: 17-21 [Abstract] [Full Text]  
• FITZGERALD, R C, BURNHAM, W R, MACDONALD, C E, WICKS, A C, PLAYFORD, R J (1998). Consideration of histopathological subtypes and biopsy techniques in Barrett's oesophagus surveillance programmes • Reply. Gut 42: 448a-448 [Full Text]  
• Trudgill, N J, Suvarna, S K, Kapur, K C, Riley, S A (1997). Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 41: 585-589 [Abstract] [Full Text]  
• Rice, T. W., Goldblum, J. R., Falk, G. W., Tubbs, R. R., Kirby, T. J., Casey, G. (1994). p53 Immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma. J. Thorac. Cardiovasc. Surg. 108: 1132-1137 [Abstract] [Full Text]